Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4ot2 | NPS | Serum albumin |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4ot2 | NPS | Serum albumin | / | 1.000 | |
2bxg | IBP | Serum albumin | / | 0.558 | |
4zbr | NPS | Serum albumin | / | 0.547 | |
2bxe | 1FL | Serum albumin | / | 0.488 | |
3nwy | GTP | Uridylate kinase | / | 0.459 | |
3lb8 | FAD | Putidaredoxin reductase | 1.18.1.5 | 0.454 | |
4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.454 | |
3tqh | NDP | Quinone oxidoreductase | / | 0.450 | |
3pjt | C2E | Diguanylate cyclase/phosphodiesterase | / | 0.448 | |
4fhi | 0S4 | Vitamin D3 receptor A | / | 0.448 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
1s0z | EB1 | Vitamin D3 receptor | / | 0.446 | |
2zbz | VDX | Vitamin D3 dihydroxylase | / | 0.444 | |
3v9y | 24L | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.444 | |
4pyt | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.444 | |
2ad5 | ADP | CTP synthase | / | 0.443 | |
2w2l | NAD | D-mandelate dehydrogenase | / | 0.443 | |
1xq6 | NAP | Uncharacterized protein At5g02240 | / | 0.442 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.442 | |
4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.442 | |
4b8z | NAP | GDP-L-fucose synthase | 1.1.1.271 | 0.442 | |
1tll | NAP | Nitric oxide synthase, brain | 1.14.13.39 | 0.441 | |
1txi | TX5 | Vitamin D3 receptor | / | 0.441 | |
1ybm | NAP | Uncharacterized protein At5g02240 | / | 0.441 | |
4nmd | FDA | Bifunctional protein PutA | / | 0.441 |